...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Not adding up!
2
Nov 15, 2021 10:37AM
2
Nov 15, 2021 11:40AM
2
Nov 15, 2021 12:43PM
2
Nov 15, 2021 01:17PM
3
Nov 15, 2021 01:46PM
2
Nov 15, 2021 02:05PM
3
Nov 15, 2021 02:21PM
1
Nov 15, 2021 04:05PM
3
Nov 15, 2021 09:09PM
1
Nov 16, 2021 09:53AM
3
Nov 16, 2021 12:02PM

Forget about Zenith Market valuation for now. , what does Newsora see in data and  current trials for Zen3694, are they thinking they are getting a deal of the century or just taking a long shot chance on the chance FDA   drug registration in the next 2 to 4 years .  That being said , Why have not 1 BP step up to take a larger partnership pice of Zenith other than just a small clinical collaboration...... 

6
Nov 16, 2021 03:37PM
Share
New Message
Please login to post a reply